Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
USPH · NYSE · United States · Services-Health Services
In shortU S PHYSICAL THERAPY INC /NV is profitable, generates cash and carries moderate debt, with revenue growing (+16.3% last year).
Financial health
Solid
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 11.1% | 54/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 5.1% | 40/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 8.2% | 41/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 10.1% | 67/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.01× | 17/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.34× | 92/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 1.16× | 81/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | – | n/a |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 2.26 | 30/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 7.8% | 51/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 1.54× | 100/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 0 of 5 | 100/100 |
| Revenue growth volatility | 3.4% | 99/100 |
| Operating margin volatility | 2.3% | 89/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 12.2% | 84/100 |
|---|---|---|
| EPS growth, 3-year average | -14.2% | 0/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 495 | 553 | 605 | 671 | 781 |
| Gross profit | 117 | 112 | 122 | 124 | 150 |
| Selling, general & admin | 47 | 46 | 52 | 58 | 69 |
| Operating income | 71 | 57 | 51 | 63 | 87 |
| Pre-tax income | 73 | 56 | 49 | 60 | 78 |
| Income tax | 15 | 12 | 12 | 15 | 20 |
| Net income | 41 | 32 | 28 | 31 | 40 |
| Diluted EPS | $2.41 | $2.25 | $1.28 | $1.84 | $1.42 |
| Diluted shares (millions) | 13 | 13 | 14 | 15 | 15 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
2.26 Grey zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
6/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 7, 2026